Complement activation by 3-mercapto-1,2-propanediol immobilized on gold surfaces

Biomaterials

Volumn 17, Issue 10, 1996, Pages 1001-1007

  Tengvall, Pentti ^a   Askendal, Agneta ^a   Lundström, Ingemar ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Complement; Ellipsometry; Mercaptoglycerol; Thiol modified gold

Indexed keywords

ALCOHOLS; ANTIBODIES; BIOASSAY; BIOMATERIALS; CELLS; ELLIPSOMETRY; GOLD; IMMUNOLOGY; SURFACES;

COMPLEMENT ACTIVATION; ENZYME IMMUNOSORBENT ASSAY; HAEMOLYTIC ASSAYS; IMMUNOGLOBULINS; MERCAPTO PROPANEDIOL; MERCAPTOGLYCEROL;

BIOCOMPATIBILITY;

ALPHA THIOGLYCEROL; ANTIBODY; BIOMATERIAL; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4D; EGTAZIC ACID; GOLD; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MAGNESIUM ION; PROPANEDIOL DERIVATIVE; PROPERDIN; UNCLASSIFIED DRUG;

ARTICLE; CHICKEN; COMPLEMENT ACTIVATION; ENZYME IMMUNOASSAY; ERYTHROCYTE; HEMOLYSIS; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SHEEP;

GALLUS GALLUS; OVIS ARIES;

EID: 0030152312     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(96)84675-8     Document Type: Article

References (28)

1. Jahns G, Haeffner-Cavaillon N, Nydegger UE, Kasatchkine MD. Complement activation and secondary cellular responses at the interface between blood and artificial surfaces. In: Williams DF, ed. CRC Critical Reviews in Biocompatibility. 1992.
2. Jahns G, Haeffner-Cavaillon N, Nydegger UE, Kasatchkine MD. Complement activation and cytokine production as consequences of immunological biocompatibility of extracorporeal circuits. Clin Mater 1993; 14: 303-336.
3. Müller-Eberhard HJ. Complement: chemistry and pathways. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation, Basic Principles and Clinical Correlations. New York: Raven Press, 1988: 21-53.
4. Law SKA, Reid KBM. Chapters 1 and 2 in: Complement, IRL Press in association with the British Society for Immunology, Oxford, UK, 1988.
5. Lachmann PJ, Hughes-Jones NC. Initiation of complement activation. In: Müller-Eberhard HJ, Miescher PA, eds. Complement. Berlin: Springer, 1985: 147-167.
6. Cheung AK, Parker CJ, Wilcox LA, Janatova J. Activation of complement by haemodialysis membranes: polyacetonitrile binds more C3a than cuprophane. Kidney Int 1990; 37: 1055-1059.
7. Kazatchkine MD, Fearon DT, Silbert JE, Austen KF. Surface-associated heparin inhibits zymozan-induced activation of the human alternative pathway by augmenting the regulatory action of the control proteins on particle-bound C3b. J Exp Med 1979; 130: 1202-1215.
8. Carreno MP, Labarre D, Jozefowicz M, Kazatchkine MD. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives. Mol Immunol 1988; 25: 165-171.
9. Montdargent B, Maillet F, Carreno MP, Jozefowitz M, Kazatchkine M, Labarre D. Regulation by sulphone groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces. Biomaterials 1993; 14: 203-208.
10. Nilsson UR, Larm O, Nilsson B, Storm K-E, Elwing H, Nilsson Ekdal K. Modification of the complement binding properties of polystyrene: effects of end-point heparin attachment. Scand J Immunol 1993; 37: 349-354.
11. Cooper NR, Nemerow GR, Mayes JT. Methods to detect and quantitate complement activation. In: Müller-Eberhard HT, Miescher PA, eds. Complement. Berlin: Springer, 1985: 455-472.
12. Elwing H, Ivarsson B, Lundström I. Complement deposition from human sera on silicon surfaces studied in situ by ellipsometry. The influence of surface wettability. Eur J Biochem 1986; 156: 359-365.
13. Li L, Elwing H. Complement activation on solid surfaces as determined by C3 deposition and hemolytic consumption. J Biomed Mater Res 1994; 28: 767-773.
14. Li L, Tengvall P, Lundström I, Elwing H. Complement activation on thiol modified gold surfaces. In: Licentiate Thesis No. 453, by Li Liu, Complement activation on wettability gradient and thiol modified surfaces, Linkoping Studies in Science and Technology, ISBN: 91-7871-416-8, 1994 (in press).
15. McCrackin FL. NBS Technical Note 479, Washington, DC: 1969.
16. de Fejter JA, Benjamins J, Veer FA. Ellipsometry as a tool to study the adsorption of synthetic and biopolymers at the air-water interface. Biopolymers 1978; 17: 1759-1772.
17. May JE, Frank MM. A new complement-mediated cytolytic mechanism - the C1-bypass activation pathway. Proc Natl Acad Sci USA 1973; 70: 649-652.
18. Ziccardi RJ. Activation of the early components of the classical complement pathway under physiologic conditions. J Immunol 1981; 126: 1769-1773.
19. Ziccardi RJ. Nature of the metal ion requirement for assembly and function of the first component of human complement (C1). J Biol Chem 1983; 258: 6187-6192.
20. Lachmann PJ, Hughes-Jones NC. Initiation of complement activation. In: Müller-Eberhard HJ, Miescher PA, eds. Complement. Berlin: Springer, 1983: 147-166.
21. Stewart WW, Johnson A, Steward MW, Whaley K, Kerr MA. The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilization. Mol Immunol 1988; 25: 1355-1361.
22. Medicus RG, Götze O, Müller-Eberhard HJ. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. J Exp Med 1976; 144: 1076-1093.
23. Chapitis J, Lepow IH. Multiple sedimenting species of properdin in human serum and interaction of human purified properdin with the third component of complement. J Exp Med 1976; 143: 241-257.
24. Lambris JD, Alsenz J, Schulz TF, Dierich MP. Mapping of the properdin-binding site in the third component of complement. Biochem J 1984; 217: 323-326.
25. Fries LF, Gaither TA, Hammer CH, Frank MM. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I. J Exp Med 1984; 160: 1640-1655.
26. Schifferli JA, Woo P, Peters DK. Complement mediated inhibition of immune precipitation. I. Role of classical and alternative pathways. Clin Exp Immunol 1982; 47: 552-562.
27. Schifferli JA, Peters DK. Complement, the immune complex lattice, and the pathophysiology of complement deficiency syndromes. Lancet 1983; ii: 957-959.
28. Czop J, Nussenzweig V. Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med 1976; 143: 615-630.